There is a risk of recurrent respiratory depression after a dose of naloxone, an opioid antagonist. Is there a risk of respiratory depression after a dose of the opioid antagonist Nalmefene? |
Share the Answer of the Day with colleagues and friends…
New to TheAnswerPage? There’s lots we’d like to share with you and we don’t want you to miss a thing! Be sure to register today for the daily “Answer of the Day” newsletter emails where you’ll gain valuable insights in small doses that fit your schedule and also be provided direct access to the archived daily content.
TheAnswerPage was launched in 1998 to provide daily education to healthcare providers in training and in practice.
Jeffrey Sherwood Block, M.D. . is a Board-certified physician anesthesiologist and adjunct Professor at the University of Miami Miller School of Medicine. Additionally, he is a highly awarded horticulturist and certified Master Gardener educator with the University of Florida’s UF/IFAS Extension Program. Dr. Block’s textbook chapter “Endocannabinoid Receptors and Medical Cannabis” (Advanced Therapeutics in Pain Medicine – CRC Press 2020) is a sentinel work on integrated pain management. Block served as the Florida Medical Association’s “Designated Expert on Botanical Medicines” authoring mandated physician education; and in 2014 was appointed by Florida’s Surgeon General to determine the rules for Florida’s first cannabis law. His consultancy’s demonstrated insight and responsible leadership are valued by both allied professionals and new industries seeking knowledge of future uses for Cannabinoid medicines.